-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Upgrades RXO to Market Outperform, Announces $30 Price Target

Benzinga·08/07/2026 15:18:30
Listen to the news
Citizens analyst Jeff Kauffman upgrades RXO (NYSE:RXO) from Market Perform to Market Outperform and announces $30 price target.